Company Snapshot
- Ticker
- RMD
- Name
- RMD
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 37067669040.000000
- Volume
- 1,111,482
- Avg Volume (3M)
- 1,018,086
RMD
RMD
Last update recent
253.07
+0.80
(+0.32%)
Market Cap
37067669040.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 5257400000.000000
- EPS
- 9.81
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 0.87%
- Net Income
- 1437904000.000000
- Net Margin
- 27.35%
- Payout Ratio
- 22.31%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- 25.78
- Forward P/E
- None
- P/S
- 7.05
- P/B
- 6.06
- Beta
- None
- Debt / Equity
- 0.14
- Current Ratio
- 2.89
- Return on Equity
- 0.23%
- Return on Assets
- 0.17%
Technicals & Returns
- Distance vs 200 DMA
- 0.27%
- 200 DMA
- 252.38
- Distance vs 50 DMA
- -1.42%
- 50 DMA
- 256.71
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as Read more
- Name
- RMD
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Michael J. Farrell BE, MBA, SM
- Employees
- 9,980
- IPO Date
- 1995-06-02
- Phone
- 858 836 5000
- Address
- None
- Website
- https://www.resmed.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-08-15 • $0.53
Latest News
Curated headlines from premium sources.
First Trust Advisors LP Acquires 3,390 Shares of ResMed Inc. $RMD
First Trust Advisors LP raised its holdings in shares of ResMed Inc. (NYSE: RMD) by 3.0% in the undefined quarter, according to its most recent 13F filing with…
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered…
Should You Continue to Hold RMD Stock in Your Portfolio?
Resmed sees strong mask sales, strategic acquisitions and international expansion despite macro and competitive challenges.
ResMed Inc. $RMD Shares Sold by Elevation Point Wealth Partners LLC
Elevation Point Wealth Partners LLC lowered its position in ResMed Inc. (NYSE: RMD) by 91.5% in the second quarter, according to the company in its most recent…
Aviso Financial Inc. Buys 9,147 Shares of ResMed Inc. $RMD
Aviso Financial Inc. increased its position in shares of ResMed Inc. (NYSE: RMD) by 4.8% in the second quarter, according to the company in its most recent dis…
IDEXX Laboratories Vs ResMed: Which Stock Could Rally?
IDEXX Laboratories' (IDXX) recent jump has investors questioning whether it's still the best bet—or if a stronger opportunity exists elsewhere. A closer look a…